Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients
Detection Principle
ImmunoAssay-Antibody
Target
Nucleocapsid and spike proteins
Testing Method Category
Testing Method
LIPS
Reported Performance
Sensitivity: 100% (nucleocapsid), 91% (spike) ; specificity: 100% (both)
Sample Size
81 patients
Peer-reviewed
no
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements